OBESITY 2008: DIET, EXERCISE, DRUGS, AND SURGERY

Size: px
Start display at page:

Download "OBESITY 2008: DIET, EXERCISE, DRUGS, AND SURGERY"

Transcription

1 OBESITY 2008: DIET, EXERCISE, DRUGS, AND SURGERY Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest CLASSIFICATION OF OVERWEIGHT AND OBESITY BY BMI Obesity Class BMI (kg/m 2 ) Underweight <18.5 Normal Overweight Obesity I II Extreme Obesity III >40 For a 40 yo woman, which BMI is associated with the lowest allcause mortality? BMI AND MORTALITY: Overall Combined NHANES I, II, and III data set BMI y y 70 y < < to < to < Flegal, JAMA,

2 Excess Deaths by Body Mass Index (NHANES) Excess Deaths Trends Over NHANES Surveys I, II, and II. Flegal, JAMA Flegal, JAMA yo woman, BMI 33. Which abnormality best predicts her 10 year mortality? METABOLIC SYNDROME Fulfill 3 or more criteria: 1. Waist circumference: 36 inches 2 Fasting blood sugar: 110 mg/dl 3 Systolic BP: 140 mm Hg 4. Triglycerides: 185 mg/dl 5. Exercise test: early stage 2 (fatigue) Waist: men > 102 cm ( > 40 in); women > 88 cm ( > 35 in) HDL: men < 40; women < 50 (or meds) Triglycerides: 150 mg/dl (or meds) BP: 130/85 (or meds) Fasting glucose: 100 mg/dl ICD-9: NCEP, Circulation,

3 CVD MORTALITY AND METABOLIC SYNDROME 19,173 men from the ACLS study CVD Mortality Normal weight Healthy 1.00 Metabolic Synd 2.06 Overweight Healthy 1.27 Metabolic Synd 1.80 Obese Healthy 2.70 Metabolic Synd yo woman, BMI 36. Motivated to begin diet therapy. Which of the following is contraindicated: 1. Meal replacement, very low calorie diet 2 Atkins diet 3 Ornish diet 4. Zone diet 5. All are contraindicated 6. None are contraindicated Katzmarzyk, Diabetes Care, 2005 VLCD s s vs LCD s: Meta-analysis analysis of 6 RCTs Trials with direct comparisons Short-term: mean 12.7 weeks Long-term: mean 1.9 years Weight loss (as % of initial weight): short-term long-term LCDs VLCDs In the last year, I have prescribed (or referred a patient for) a very low calorie diet (VLCD) for weight loss. 1. Yes 2 No (p) (0.001) (0.2) Tsai and Wadden, Obesity,

4 COMPARISON OF ATKINS, ORNISH, WEIGHT WATCHERS, AND ZONE 160 patients, randomly assigned Intention to treat at 1 year Atkins Ornish WW Zone Wt Loss (kg) Completers (%) Completers at 1 year Atkins Ornish WW Zone Wt Loss (kg) COMPARISON OF ATKINS, ORNISH, WEIGHT WATCHERS, AND ZONE Weight loss associated with adherence, but not diet type Each group: 25% lost 5%, 10% lost 10% of initial weight Each diet reduced LDL/HDL by 10% No significant effects on BP or glucose CRP and insulin reductions associated with weight loss, but not diet Dansinger, JAMA 2005 Dansinger, JAMA, 2005 COMPARISON OF ATKINS, ZONE, ORNISH, AND LEARN 311 patients, randomly assigned Intention to treat at 1 year Atkins Zone LEARN Ornish Wt Loss (kg) 4.7 * LDL-C (mg/dl) HDL-C (mg/dl) 4.9* Glucose (mg/dl) SBP (mm Hg) -7.6* DBP (mm Hg) -4.4* yo woman, BMI 36. Motivated to begin diet therapy. Which of the following is contraindicated: 1. Meal replacement, very low calorie diet 2 Atkins diet 3 Ornish diet 4. Zone diet 5. All are contraindicated 6. None are contraindicated * p < 0.5 Gardner, JAMA

5 EXERCISE FOR OBESITY Meta-analysis analysis of 43 RCTs: : 3476 participants Exercise vs no Rx small weight losses Exercise plus diet vs diet alone -1.1 kg Increased intensity of exercise -1.5 kg Exercise without weight loss -BP, -TG, -FBS Shaw, Cochrane, 2006 FITNESS AND MORTALITY Aerobics Center Longitudinal Study 25,714 men, 44 years old, 14 year observational study CV death (RR) normal overweight obese Fit Not fit Total death (RR) normal overweight obese Fit Not fit Wei, JAMA 1999 CVD MORTALITY AND METABOLIC SYNDROME 19,173 men from the ACLS study CVD Mortality Fitness adjusted RR Normal weight Healthy Metabolic Syn Overweight Healthy Metabolic Syn Obese Healthy Metabolic Syn PEDOMETERS INCREASE PHYSICAL ACTIVITY Meta-analysis analysis of 26 Studies: 2767 participants RCTS (8): Pedometer users increased 2491 steps Observational studies (18) Pedometer users increased 2183 steps Overall: 26.9% increase in steps Goal (10,000 steps per day) important predictor) BMI decreased 0.38; BP decreased 3.8 mmhg Katzmarzyk, Diabetes Care, 2005 Bravata, JAMA

6 40 yo woman, BMI 33. Which abnormality best predicts 10 year all cause mortality? 1. Waist circumference: 36 inches 2 Fasting blood sugar: Systolic BP: Triglycerides: Exercise test: early stage 2 (fatigue) 40 yo woman, BMI 36. Much to your surprise (and satisfaction), she has lost 35 pounds. In order to maintain her new weight, her lifelong daily calorie intake should be: kcals kcals kcals kcals kcals SUCCESSFUL WEIGHT LOSS MAINTENANCE 3000 subjects in National Weight Control Registry: 30-lb weight loss for 1-year Average weight loss 33 kg (10 BMI units less), average weight maintenance 5.5 years 45 years old, 80% women, 97% Caucasian 46% overweight as child, 46% one parent obese, 27% both parents SUCCESSFUL WEIGHT LOSS MAINTENANCE High levels of physical activity Women 2545 kcal/week, men 3293 kcal/week (1-hour moderate intensity per day Only 9% report no physical activity Diet low in fat, high in carbohydrate 1381 kcal day, 24% fat, 19% protein, 56% CHO 4.87 meals or snacks/day Fast food 0.74/week Regular self-monitoring of weight 44% weigh once per day; 31% once per week Wing, Am J Clin Nutr, 2005 Wing, Am J Clin Nutr,

7 40 yo woman, BMI 36. Much to your surprise, she has lost 35 pounds. In order to maintain her new weight, her lifelong daily calorie intake should be: kcals kcals kcals kcals kcals GOALS OF MANAGEMENT Be as fit as possible at current weight Prevent further weight gain If successful at 1 and 2, begin weight loss BEHAVIOR THERAPY Key elements Goal setting Self-monitoring Stimulus control Cognitive skills BEHAVIOR THERAPY Meta-Analysis of 36 Studies Behavioral vs placebo -2.5 kg more weight lost Behavior plus diet and exercise Better in 5 of 6 studies -4.9 kg more weight lost Fabricatore, J Am Diet Assoc, 2007 Shaw, Cochrane Database,

8 In the last year, I have prescribed a medication for weight loss. The medication I most commonly prescribe for weight loss is: 1. Yes 2 No 1. Phentermine 2. Sibutramine 3. Orlistat 4. Topiramate 5. Exenatide 6. Other LONG TERM PHARMACOTHERAPY OF OBESITY Review of all RCT s more than 36 weeks published since 1960 Weight loss in excess of placebo: % of initial kg s Phen-fen 11.0% 9.6 kg Phentermine 8.1% 7.9 kg Sibutramine 5.0% 4.3 kg Orlistat 3.4% 3.4 kg Dexfenfluramine 3.0% 2.5 Kg Fluoxetine -0.4% -0.4 kg Diethyproprion -1.5% -1.5 kg Glazer, Arch Int Med 2001 OFF-LABEL USE Buproprion NA re-uptake inhibitor RCT of 327 obese pts, 24 weeks; Wt. loss: 2% placebo vs. 5% in 300/400 mg Metformin Wt loss: -2 kg with drug vs. -0 kg with placebo vs. -4 kg with lifestyle in DPP Exenatide (Byetta) - Wt loss: -4-5 kg in open label study at 80+ weeks 8

9 RIMONABANT Meta-analysis of 4 studies Rimonobant plus diet vs diet alone, for 1 year or more Rimonabant kg loss (5%) Improved waist circ, BP, HDL, TG Attrition 40%: GI, psychiatric, neuro Rimonobant 5 mg -1.3 kg loss RIMONABANT June 2007 FDA advisory committee recommends that rimonabant not be sold in the US pending further study of depression and suicidality. Sanofi withdraws bid to sell rimonabant in US Curioni, Cochrane, 2006 RIMONABANT AND CAD: The STRADIVARIUS Trial 839 patients, randomly assigned, 18 months f/u Rimonabant Placebo p Weight (kg) PAV % TAV mm Psych effects PRINCIPLES OF DRUG THERAPY NIH: BMI > 30 kg/m 2 or 27 kg/m 2 with co-morbidity (but in practice almost never) Motivated to begin structured exercise and low calorie diet Begin medications at completion of one month successful diet and exercise Continue medications only if additional weight loss achieved in first month with meds Nissen, JAMA

10 Wouldn t It Be Easier Just To Have Surgery? In the last year, I have referred a patient for weight loss surgery. 1. Yes 2 No 57 yo woman, BMI 42 with diabetes, hypertension, and creatinine 1.4 asks about bariatric surgery. Her risk of mortality 30 days post-op is 1. 1 in in in in in 10 Who s Getting Surgery? Approved by most payers; cost effective Recent review indicates more surgeries done in: women those with private insurance those living in wealthier zip codes Santry HP JAMA

11 Restrictive Types of Surgery Horizontal Gastroplasties Vertical Banded Gastroplasty (VGB) Silastic Ring Vertical Gastroplasty (SRVG) Adjustable Lap-Band Malabsorptive Jejunoileal Bypass (JIB) Biliopancreatic Diversion (BPD) Duodenal Switch Long Limb Gastric Bypass BANDING VS. CONVENTIONAL THERAPY FOR DIABETES RCT of 60 patients. 55 completed 2 year follow-up Banding Conventional p Remission 22 (73%) 4 (13%).001 Weight Loss 20.7% 1.7%.001 HbA Restrictive with Malabsorptive Component Roux-en-Y Gastric Bypass (RYGPB) Dixon, JAMA 2008 BARIATRIC SURGERY META-ANALYSIS Review of bariatric surgery (136 studies), , 22,092 patients weight loss (kgs) BMI decrease % excess weight loss Total Gastric Banding Gastric Bypass Gastroplasty Biliopancreatic diversion or duodenal switch Buchwald, JAMA, 2004 % Resolution Comorbidity Resolution of Comorbidities Bariatric Surgery A Systematic Review and Meta-analysis Buchwald H. et al. JAMA. 2004; 292(14): Diabetes Hyperlipidemia HTN Sleep apnea Band VBG GBP D Switch 11

12 BARIATRIC SURGERY META-ANALYSIS Mortality Rate After Bariatric Surgery Review of bariatric surgery (136 studies), 22,092 patients Operative Mortality Gastric Banding 0.1% Gastric Bypass 0.5% Gastroplasty 0.1% Biliopancreatic diversion or duodenal switch 1.1% Buchwald, JAMA, 2004 Flum, JAMA yo woman, BMI 42 with diabetes, hypertension, and creatinine 1.4 asks about bariatric surgery. Her risk of mortality 30 days post-op is 1. 1 in in in in in 10 Bariatric Surgery and Mortality Swedish Obese Subjects Study 4047 subjects, surgery vs. matched control years f/u Max weight loss % Final weight loss % Control 2 Gastric bypass Vertical banded Gastroplasty Banding Sjostrom, NEJM,

13 Bariatric Surgery and Mortality Swedish Obese Subjects Study Bariatric Surgery and Mortality Retrospective Cohort, Utah Surgical Practice Deaths HR Rate MI deaths Cancer deaths Control Surgery (p = 0.04) NNT 77 over 11 years (approx 850 per year) 9949 patients with surgery and 9628 who applied for drivers license, 7.1 years follow-up Deaths HR Rate CV deaths Cancer deaths Control Surgery (p = 0.001) NNT 513 over 7 years (approx 3600 per year) Sjostrom, NEJM, 2007 Adams, NEJM, 2007 The Magic Formula 13

A SYSTEMATIC APPROACH TO

A SYSTEMATIC APPROACH TO A SYSTEMATIC APPROACH TO OBESITY Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest Prevalence of Obesity (Adults): 2008

More information

Prevalence of Obesity (Adults) Prevalence of Obesity (Children) CURRENT STRATEGIES IN. Obesity: 33.8% Men: 32.2% Women: 35.5%

Prevalence of Obesity (Adults) Prevalence of Obesity (Children) CURRENT STRATEGIES IN. Obesity: 33.8% Men: 32.2% Women: 35.5% CURRENT STRATEGIES IN OBESITY Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest Prevalence of Obesity (Adults) Obesity:

More information

NEW DEVELOPMENTS IN ASSESSMENT AND TREATMENT OF OBESITY

NEW DEVELOPMENTS IN ASSESSMENT AND TREATMENT OF OBESITY Prevalence of Obesity (Adults)! Obesity: 33.8% Men: 32.2% Women: 35.5% Overweight + obesity: 68% Men: 72.3% Women: 64.1% Severe Obesity: 6% Flegal JAMA 2010 Men and Women Aged 40 to 59 Years in 1999-2000

More information

CURRENT STRATEGIES IN OBESITY

CURRENT STRATEGIES IN OBESITY Prevalence of Obesity (Adults)! Obesity: 33.8% Men: 32.2% Women: 35.5% Overweight + obesity: 68% Men: 72.3% Women: 64.1% Severe Obesity: 6% Flegal JAMA 2010 Men and Women Aged 40 to 59 Years in 1999-2000

More information

OBESITY: FACTS AND FICTIONS

OBESITY: FACTS AND FICTIONS Robert B. Baron MD MS Prevalence of Obesity (Adults) Obesity: 33.8% Men: 32.2% Women: 35.5% Professor of Medicine Associate Dean for GME and CME Director, UCSF Osher Mini Med School Director, UCSF Weight

More information

CURRENT STRATEGIES IN MANAGEMENT OF OBESITY. Prevalence of Obesity (Adults)

CURRENT STRATEGIES IN MANAGEMENT OF OBESITY. Prevalence of Obesity (Adults) CURRENT STRATEGIES IN MANAGEMENT OF OBESITY Robert B. Baron MD MS Professor of Medicine Associate Dean for GME and CME Director, UCSF Weight Management Program Declaration of full disclosure: No conflict

More information

MANAGEMENT OF OBESITY: A

MANAGEMENT OF OBESITY: A MANAGEMENT OF OBESITY: A Systematic Approach In the United States (over the last decade) the overall prevalence of obesity is: Robert B. Baron MD MS Professor of Medicine Associate Dean for GME and CME

More information

Obesity Management in Women

Obesity Management in Women Defining Obesity Obesity Management in Women Alka M. Kanaya, M.D. Assistant Professor of Medicine October 19, 2007 An increase in fat accumulation, to the extent that health may be adversely affected BMI

More information

UCSF Acknowledgments

UCSF Acknowledgments CURRENT STRATEGIES FOR TREATING OBESITY Robert B. Baron MD MS Professor of Medicine Associate Dean for GME and CME Founding Director, UCSF Weight Management Program Declaration of full disclosure: No conflict

More information

Disclosures OBESITY. Overview. Obesity: Definition. Prevalence of Obesity is Rising. Obesity as a Risk Factor. None

Disclosures OBESITY. Overview. Obesity: Definition. Prevalence of Obesity is Rising. Obesity as a Risk Factor. None Disclosures None OBESITY Florencia Halperin, M.D. Medical Director, Program for Management Brigham and Women s Hospital Instructor in Medicine, Harvard Medical School Overview Obesity: Definition Definition

More information

Effect of Bariatric Surgery on Cardio-Metabolic Outcomes

Effect of Bariatric Surgery on Cardio-Metabolic Outcomes Effect of Bariatric Surgery on Cardio-Metabolic Outcomes Disclosure Research support from Bariatric Advantage (supplements donated for research study) Anne Schafer, MD Associate Professor of Medicine and

More information

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI

More information

Edward Melanson, Ph.D., Associate Professor, Division of Endocrinology, Metabolism, and Diabetes University of Colorado Denver

Edward Melanson, Ph.D., Associate Professor, Division of Endocrinology, Metabolism, and Diabetes University of Colorado Denver Edward Melanson, Ph.D., Associate Professor, Division of Endocrinology, Metabolism, and Diabetes University of Colorado Denver 45 y/o man Medications: none Social Hx: moderate alcohol intake (1-2 cans

More information

Other Ways to Achieve Metabolic Control

Other Ways to Achieve Metabolic Control Other Ways to Achieve Metabolic Control Nestor de la Cruz- Muñoz, MD, FACS Associate Professor of Clinical Surgery Chief, Division of Laparoendoscopic and Bariatric Surgery DeWitt Daughtry Family Department

More information

Diabetes Treatment Update

Diabetes Treatment Update Diabetes Treatment Update Timothy C. Evans, MD PhD FACP University of Washington Department of Medicine Disclosure: Dr. Evans has no significant financial interest in any of the products or manufacturers

More information

OBESITY IN PRIMARY CARE

OBESITY IN PRIMARY CARE OBESITY IN PRIMARY CARE Obesity- definition Is a chronic disease In ICD 10 E66 Overweight and obesity are defined as abnormal or excessive fat accumulation that may impair health. Obesity is a leading

More information

Treating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition

Treating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition Treating Type 2 Diabetes by Treating Obesity Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition 2 Center Stage Obesity is currently an epidemic in the United States, with

More information

OBESITY IN TYPE 2 DIABETES

OBESITY IN TYPE 2 DIABETES OBESITY IN TYPE 2 DIABETES Ashley Crowl, PharmD, BCACP Assistant Professor University of Kansas Objectives Review how to manage obesity in patients with type-2 diabetes mellitus Compare antiobesity agents

More information

A Bariatric Patient in my Waiting Room: Choosing the Right Patient for the Right Operation: Bariatric Surgery Indications

A Bariatric Patient in my Waiting Room: Choosing the Right Patient for the Right Operation: Bariatric Surgery Indications A Bariatric Patient in my Waiting Room: Choosing the Right Patient for the Right Operation: Bariatric Surgery Indications Shahzeer Karmali MD FRCSC FACS Associate Professor Surgery University of Alberta

More information

No relevant financial relationships

No relevant financial relationships MANAGEMENT OF LIPID DISORDERS Balancing Benefits and harms Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial relationships baron@medicine.ucsf.edu

More information

OBESITY: The Growing Epidemic and its Medical Impact

OBESITY: The Growing Epidemic and its Medical Impact OBESITY: The Growing Epidemic and its Medical Impact Ray Plodkowski, MD Co-Chief, Chief, of Division of Medical Nutrition, University of Nevada School of Medicine. Chief, Endocrinology & Metabolism, Sachiko

More information

JAMA February 10, 2010 Laparoscopic Adjustable Banding in Severely Obese Adolescents: A Randomized Trial

JAMA February 10, 2010 Laparoscopic Adjustable Banding in Severely Obese Adolescents: A Randomized Trial JAMA February 10, 2010 Laparoscopic Adjustable Banding in Severely Obese Adolescents: A Randomized Trial Daniel DeUgarte, MD Division of Pediatric Surgery Surgical Director, UCLA FIT Program Bariatric

More information

Obesity D R. A I S H A H A L I E K H Z A I M Y

Obesity D R. A I S H A H A L I E K H Z A I M Y Obesity D R. A I S H A H A L I E K H Z A I M Y Objectives Definition Pathogenesis of obesity Factors predisposing to obesity Complications of obesity Assessment and screening of obesity Management of obesity

More information

You should try to lose some weight : an evidence- based approach to diet and weight loss Ridge Meadows Hospital Grand Rounds 14 September 2015

You should try to lose some weight : an evidence- based approach to diet and weight loss Ridge Meadows Hospital Grand Rounds 14 September 2015 You should try to lose some weight : an evidence- based approach to diet and weight loss Ridge Meadows Hospital Grand Rounds 14 September 2015 Barbara Hughes, MD, FRCPC DefiniMons Body Mass Index=weight

More information

Faculty/Presenter Disclosure

Faculty/Presenter Disclosure Weight loss & Obesity WHAT S NEW & EXCITING? Tina Korownyk Dept of Family Medicine, UofA Faculty/Presenter Disclosure Faculty/Presenter: Tina Korownyk Relationships with commercial interests: None 1 Drowning

More information

Conflict of Interest Disclosure Obesity Treatment: What Is a Staged Approach & What Does it Mean for Clinicians?

Conflict of Interest Disclosure Obesity Treatment: What Is a Staged Approach & What Does it Mean for Clinicians? Conflict of Interest Disclosure Obesity Treatment: What Is a Staged Approach & What Does it Mean for Clinicians? Nothing to declare Nancy F. Krebs, MD, MS University of Colorado Denver School of Medicine

More information

Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m.

Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m. Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, 2018 10:15 a.m. 11:00 a.m. Type 2 diabetes mellitus (T2DM) is closely associated with obesity, primarily through the link

More information

Disclosures. Obesity and Its Challenges: Outline. Outline 5/2/2013. Lan Vu, MD Division of Pediatric Surgery Department of Surgery

Disclosures. Obesity and Its Challenges: Outline. Outline 5/2/2013. Lan Vu, MD Division of Pediatric Surgery Department of Surgery Obesity and Its Challenges: Bariatric Surgery: Why or Why Not I have nothing to disclose Disclosures Lan Vu, MD Division of Pediatric Surgery Department of Surgery Outline Growing obesity epidemic Not

More information

Lecture Goals. Body Mass Index. Obesity Definitions. Bariatric Surgery What the PCP Needs to Know 11/17/2009. Indications for bariatric Surgeries

Lecture Goals. Body Mass Index. Obesity Definitions. Bariatric Surgery What the PCP Needs to Know 11/17/2009. Indications for bariatric Surgeries Bariatric Surgery What the PCP Needs to Know Mouna Abouamara Assistant Professor Internal Medicine James H Quillen College Of Medicine Lecture Goals Indications for bariatric Surgeries Different types

More information

Current Trends in Bariatric Surgery

Current Trends in Bariatric Surgery Current Trends in Bariatric Surgery 9.28.2017 Abraham Krikhely, MD, FACS, FASMBS Assistant Professor of Surgery, CUMC Center of Minimal Access, Metabolic and Weight Loss Surgery Outline Why consider surgery

More information

Update in Obesity: the 10 Most Interesting Studies in DGIM Grand Rounds January 26, 2010

Update in Obesity: the 10 Most Interesting Studies in DGIM Grand Rounds January 26, 2010 Update in Obesity: the 10 Most Interesting Studies in 2009 DGIM Grand Rounds January 26, 2010 Adam Gilden Tsai, MD, MSCE Assistant Professor of Medicine Acknowlegements Conflicts of Interest: none Slides

More information

Policy Specific Section: April 14, 1970 June 28, 2013

Policy Specific Section: April 14, 1970 June 28, 2013 Medical Policy Bariatric Surgery Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Surgery Original Policy Date: Effective Date: April 14, 1970 June 28, 2013 Definitions

More information

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials PREVENTING CARDIOVASCULAR DISEASE IN WOMEN: Current Guidelines for Hypertension, Lipids and Aspirin Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial

More information

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION Management of Hypertension: Treatment Thresholds and Medication Selection Robert B. Baron, MD MS Professor and Associate Dean Declaration of full disclosure: No conflict of interest Presentation Goals

More information

Obesity Management in Type 2 Diabetes

Obesity Management in Type 2 Diabetes Obesity Management in Type 2 Diabetes Clare J. Lee, MD, MHS Assistant Professor of Medicine, Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University Disclosures None Objectives Describe

More information

Overview of Management of Obesity

Overview of Management of Obesity Overview of Management of Obesity Srividya Kidambi, MD, MS Division of Endocrinology, Metabolism, and Clinical Nutrition Medical College of Wisconsin, Milwaukee, WI I have nothing to disclose. Objectives

More information

13/09/2012. Therapeutic Options in Obesity. Clinical scenario (1) Clinical Symposium. Clinical scenario (2) Clinical scenario (3)

13/09/2012. Therapeutic Options in Obesity. Clinical scenario (1) Clinical Symposium. Clinical scenario (2) Clinical scenario (3) 2 nd AME Italian Meeting Associazione Medici Endocrinologi Joint Meeting with AACE American Association of Clinical Endocrinologists Reggio Emilia, Italy - November 8-10, 2002 Clinical Symposium Therapeutic

More information

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials MANAGEMENT OF HYPERLIPIDEMIA AND CARDIOVASCULAR RISK IN WOMEN: Balancing Benefits and Harms Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial

More information

OBESITY:Pharmacotherapy Vs Surgery

OBESITY:Pharmacotherapy Vs Surgery OBESITY:Pharmacotherapy Vs Surgery Dr. Ranajit Sen Chowdhury Associate Professor Department of Medicine Sir Salimullah Medical College & Mitford Hospital. 1 Historical Perspective Paleolithic Era > 25,000

More information

Bariatric Surgery Update

Bariatric Surgery Update Bariatric Surgery Update Alexander Perez, MD, FACS Professor of Surgery Chief, Division Minimally Invasive and Foregut Surgery Speaker Disclosure Dr. Perez has disclosed that the has no actual or potential

More information

Surgical Therapy for Morbid Obesity. Janeen Jordan, PGY 5 Surgical Grand Rounds April 7, 2008

Surgical Therapy for Morbid Obesity. Janeen Jordan, PGY 5 Surgical Grand Rounds April 7, 2008 Surgical Therapy for Morbid Obesity Janeen Jordan, PGY 5 Surgical Grand Rounds April 7, 28 Obesity BMI > 3 kg/m 2 Moderate 35-4 kg/m 2 Morbid >4 kg/m 2 1.7 BILLION Overweight Adults in the world 63 MILLION

More information

Bariatric Surgery: The Primary Care Approach

Bariatric Surgery: The Primary Care Approach The 8 th Annual Conference of the Lebanese Society of Family Medicine October 25 th 2009 Bariatric Surgery: The Primary Care Approach Bassem Y. Safadi, MD, FACS Associate Professor of Clinical Surgery

More information

1 Mechanick JI, Garber AJ, Handelsman Y, Garvey WT. Endocr Pract. 2012;18: Depression. Cancer. Gallbladder Disease

1 Mechanick JI, Garber AJ, Handelsman Y, Garvey WT. Endocr Pract. 2012;18: Depression. Cancer. Gallbladder Disease Percent 4 3 2 1 Obese Overweight Extremely obese Note: Age-adjusted by the direct method to the year 2 US Bureau of the Census using age groups 2 39, 4 59, and 6 74 years. Pregnant females excluded. Overweight

More information

Case Presentation: Morbidly Obese Adolescent. Daniel DeUgarte,, MD Division of Pediatric Surgery Surgical Director, UCLA FIT Program

Case Presentation: Morbidly Obese Adolescent. Daniel DeUgarte,, MD Division of Pediatric Surgery Surgical Director, UCLA FIT Program Case Presentation: Morbidly Obese Adolescent Daniel DeUgarte,, MD Division of Pediatric Surgery Surgical Director, UCLA FIT Program R.A. 15y/o Adolescent Girl 138kg / 160.8cm 53.4 BMI Overweight since

More information

Bariatric surgery: Impact on Co-morbidities and Weight Loss Expectations ALIYAH KANJI, MD FRCSC MIS AND BARIATRIC SURGERY SEPTEMBER 22, 2018

Bariatric surgery: Impact on Co-morbidities and Weight Loss Expectations ALIYAH KANJI, MD FRCSC MIS AND BARIATRIC SURGERY SEPTEMBER 22, 2018 Bariatric surgery: Impact on Co-morbidities and Weight Loss Expectations ALIYAH KANJI, MD FRCSC MIS AND BARIATRIC SURGERY SEPTEMBER 22, 2018 Disclosures None Objectives Review expected weight loss from

More information

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of

More information

OBESITY MANAGEMENT: DIET/EXERCISE, NEW DRUGS AND/OR SURGERY?

OBESITY MANAGEMENT: DIET/EXERCISE, NEW DRUGS AND/OR SURGERY? OBESITY MANAGEMENT: DIET/EXERCISE, NEW DRUGS AND/OR SURGERY? ERIC VOLCKMANN, MD DIRECTOR OF BARIATRIC SURGERY OCTOBER 20, 2017 OBJECTIVES Define prevalence and health effects of obesity Discuss different

More information

6/23/2011. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle

6/23/2011. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle Bariatric Surgery: What the Primary Care Provider Should Know 2,000 B.C. 2,000 A.D. Case Presentation: Rachelle 35 year-old woman with morbid obesity. 5 1 236 lbs BMI 44.5 PMHx: mild depression obstructive

More information

Placebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN

Placebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING THE DECREASE

More information

SURGICAL TREATMENT FOR OBESITY: WHATS THE BEST OPTION? Natan Zundel, MD, FACS

SURGICAL TREATMENT FOR OBESITY: WHATS THE BEST OPTION? Natan Zundel, MD, FACS SURGICAL TREATMENT FOR OBESITY: WHATS THE BEST OPTION? Natan Zundel, MD, FACS Professor of Surgery Vice-Chairman Department of Surgery Florida International University Herbert Wertheim College of Medicine

More information

Bariatric Surgery Update

Bariatric Surgery Update Friday General Session Bariatric Surgery Update Alex Perez, MD Chief, Division of Minimally Invasive and Foregut Surgery James E. Thompson, MD Family Distinguished Professor in Surgical Simulation Co Director,

More information

Placebo-Controlled Statin Trials Prevention Of CVD in Women"

Placebo-Controlled Statin Trials Prevention Of CVD in Women MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest

More information

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator

More information

The Changing Shape of Bariatric Surgery

The Changing Shape of Bariatric Surgery Measuring Obesity The Changing Shape of Bariatric Surgery D. Scott Diamond, MD FACS Determined by height and weight Comparison to ideal body weight/height BMI = weight(kg) height(m) 2 BMI = weight(lb)*

More information

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient

More information

Nutritional Aspects of Obesity Management. Christy Olson MS, RD, LD, CDE

Nutritional Aspects of Obesity Management. Christy Olson MS, RD, LD, CDE Nutritional Aspects of Obesity Management Christy Olson MS, RD, LD, CDE Relevant Disclosure and Resolution Under Accreditation Council for Continuing Medical Education guidelines disclosure must be made

More information

Diabetes Mellitus: Implications of New Clinical Trials and New Medications

Diabetes Mellitus: Implications of New Clinical Trials and New Medications Diabetes Mellitus: Implications of New Clinical Trials and New Medications Estimates of Diagnosed Diabetes in Adults, 2005 Alka M. Kanaya, MD Asst. Professor of Medicine UCSF, Primary Care CME October

More information

Learning Objectives

Learning Objectives Learning Objectives Assess the key findings of the McMaster meal replacement therapy (MRT) study Identify patients with T2DM who are candidates for MRT Develop a plan to implement partial MRT into a patient

More information

Bariatric Surgery: Indications and Ethical Concerns

Bariatric Surgery: Indications and Ethical Concerns Bariatric Surgery: Indications and Ethical Concerns Ramzi Alami, M.D. F.A.C.S Assistant Professor of Surgery American University of Beirut Medical Center Beirut, Lebanon Nothing to Disclose Determined

More information

Introduction Evidence-Based Guidelines

Introduction Evidence-Based Guidelines EXECUTIVE SUMMARY Introduction An estimated 97 million adults in the United States are overweight or obese, a condition that substantially raises their risk of morbidity from hypertension, dyslipidemia,

More information

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome: Is It A Valid Concept? YES The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA

More information

SURGICAL MANAGEMENT OF OBESITY. Anne Lidor, MD, MPH Professor of Surgery Chief, Division of Minimally Invasive and Bariatric Surgery

SURGICAL MANAGEMENT OF OBESITY. Anne Lidor, MD, MPH Professor of Surgery Chief, Division of Minimally Invasive and Bariatric Surgery SURGICAL MANAGEMENT OF OBESITY Anne Lidor, MD, MPH Professor of Surgery Chief, Division of Minimally Invasive and Bariatric Surgery Multi-Factorial Causes of Morbid Obesity include: Genetic Environmental

More information

Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes

Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes Results of the STAMPEDE Trial Philip R Schauer, Deepak L Bhatt, John P Kirwan, Kathy Wolski, Stacy A Brethauer,

More information

What Are the Effects of Weight Management Pharmacotherapy on Lipid Metabolism and Lipid Levels?

What Are the Effects of Weight Management Pharmacotherapy on Lipid Metabolism and Lipid Levels? What Are the Effects of Weight Management Pharmacotherapy on Lipid Metabolism and Lipid Levels? Daniel Bessesen, MD Professor of Medicine University of Colorado School of Medicine Chief of Endocrinology,

More information

The prevalence of obesity in adults has doubled over the past 30 years

The prevalence of obesity in adults has doubled over the past 30 years Obesity in America: Facts and Fiction MICHAEL G. PERRI, PhD Professor, Clinical and Health Psychology Interim Dean, College of Public Health and Health Professions University of Florida Overview: Key Questions

More information

10/16/2014. Normal Weight: BMI Overweight: BMI >25 Obese: BMI >30 Morbidly Obese: BMI >40 or >35 with 2 comorbidities

10/16/2014. Normal Weight: BMI Overweight: BMI >25 Obese: BMI >30 Morbidly Obese: BMI >40 or >35 with 2 comorbidities Brinton Clark, MD, MPH Department of Medical Education Providence Portland Medical Center October 25 th, 2014 Oregon Society of Physician Assistants Fall Conference 45 yo woman with BMI=40kg/m2 (weight

More information

Primary Outcome Results of DiRECT the Diabetes REmission Clinical Trial

Primary Outcome Results of DiRECT the Diabetes REmission Clinical Trial Finding a practical management solution for T2DM, in primary care Primary Outcome Results of DiRECT the Diabetes REmission Clinical Trial Mike Lean, Roy Taylor, and the DiRECT Team IDF Abu Dhabi, December

More information

Part 1: Obesity. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes 10/15/2018. Objectives.

Part 1: Obesity. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes 10/15/2018. Objectives. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes Stephen D. Sisson MD Objectives To review dietary recommendations in the following conditions: Obesity Hypertension Diabetes

More information

Obesity Medicine Sacramento

Obesity Medicine Sacramento Dr Ed Hendricks Obesity Medicine Sacramento 11:00-11:55 WS #31: The Role of Duromine in Obesity Management - The US experience 12:05-13:00 WS #39: The Role of Duromine in Obesity Management - The US experience

More information

Chairman s Rounds, 02/15/2011

Chairman s Rounds, 02/15/2011 Chairman s Rounds, 02/15/2011 Edward Lipkin, MD Associate Professor, Department of Medicine Division of Metabolism, Endocrinology and Nutrition University of Washington Predictive factors in patient s

More information

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest

More information

Learning Objectives. Currently Available Options. Update on Weight Loss Pharmacotherapy. Dan Bessesen, MD

Learning Objectives. Currently Available Options. Update on Weight Loss Pharmacotherapy. Dan Bessesen, MD Update on Weight Loss Pharmacotherapy Dan Bessesen, MD Daniel.bessesen@ucdenver.edu Learning Objectives List the medications that are currently available for the treatment of obesity, describe their mechanisms

More information

Update in Hypertension

Update in Hypertension Update in Hypertension Eliseo J. PérezP rez-stable MD Professor of Medicine DGIM, Department of Medicine UCSF 20 May 2008 Declaration of full disclosure: No conflict of interest (I have never been funded

More information

Bariatric Surgery and Bone Health

Bariatric Surgery and Bone Health Bariatric Surgery and Bone Health No conflicts of interest Anne Schafer, MD Assistant Professor of Medicine Division of Endocrinology & Metabolism July 26, 202 BMI and Fracture Risk Low BMI is associated

More information

Obesity Management. Ross M. Miller, MD, MPH

Obesity Management. Ross M. Miller, MD, MPH Obesity Management Ross M. Miller, MD, MPH For a CME/CEU version of this article please go to http://www.namcp.org/cmeonline.htm, and then click the activity title. Summary Currently, obesity is the number

More information

Weight Loss Surgery. Outline 3/30/12. What Every GI Nurse Needs to Know. Define Morbid Obesity & its Medical Consequences. Treatments for Obesity

Weight Loss Surgery. Outline 3/30/12. What Every GI Nurse Needs to Know. Define Morbid Obesity & its Medical Consequences. Treatments for Obesity 3/30/12 Weight Loss Surgery What Every GI Nurse Needs to Know Kenneth A Cooper, D.O. March 31, 2012 Outline Define Morbid Obesity & its Medical Consequences Treatments for Obesity Bariatric (Weight-loss)

More information

ADVANCES IN MANAGEMENT OF HYPERTENSION

ADVANCES IN MANAGEMENT OF HYPERTENSION Advances in Management of Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Prevalence 29%; Blacks 33.5%

More information

Obesity: Pharmacologic and Surgical Management

Obesity: Pharmacologic and Surgical Management Obesity: Pharmacologic and Surgical Management ADRIENNE YOUDIM, MD, FACP ASSOCIATE PROFESSOR OF MEDICINE, UCLA ASSISTANT PROFESSOR OF MEDICINE, CEDARS SINAI MEDICAL CENTER JANUARY 2018 Defining Obesity

More information

MEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT. Page: 1 of 6

MEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT. Page: 1 of 6 Page: 1 of 6 MEDICAL POLICY MEDICAL POLICY DETAILS Medical Policy Title MEDICAL/ NON-SURGICAL WEIGHT MANAGEMENT PROGRAMS and SERVICES Policy Number 11.01.01 Category Contract Clarification Effective Date

More information

Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes. Stephen D. Sisson MD

Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes. Stephen D. Sisson MD Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes Stephen D. Sisson MD Objectives To review dietary recommendations in the following conditions: Obesity Hypertension Diabetes

More information

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: Executive Summary 1 3

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: Executive Summary 1 3 Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: Executive Summary 1 3 Expert Panel on the Identification, Evaluation, and Treatment of Overweight

More information

Diabetes Head To Toe May 31, Obesity in Canada. Six million Canadians are living with obesity

Diabetes Head To Toe May 31, Obesity in Canada. Six million Canadians are living with obesity Medical & Surgical Options for the Bariatric Patient Michelle Mountain, RD, B.Sc Obesity in Canada 1 in 5 adults are obese Six million Canadians are living with obesity 1 in 10 children have clinical obesity

More information

Methods. Background and Objectives STRADIVARIUS

Methods. Background and Objectives STRADIVARIUS STRADIVARIUS Effect of on Progression of Atherosclerosis in Patients with Abdominal Obesity and Coronary Artery Disease Steven E. Nissen MD Stephen J. Nicholls MBBS PhD, Kathy Wolski MPH, Josep Rodés-Cabau

More information

2/10/2014 CARDIOVASCULAR BENEFITS OF BARIATRIC SURGERY. Disclosures. My Background

2/10/2014 CARDIOVASCULAR BENEFITS OF BARIATRIC SURGERY. Disclosures. My Background CARDIOVASCULAR BENEFITS OF BARIATRIC SURGERY Anthony M Gonzalez, MD, FACS, FASMBS Associate Professor of Surgery, FIU College of Medicine Chief of Surgery, Baptist Hospital of Miami Medical Director Bariatric

More information

How to Achieve Medical Weight Loss in 2012

How to Achieve Medical Weight Loss in 2012 How to Achieve Medical Weight Loss in 2012 Gary D. Foster, Ph.D. Laure H. Carnell Professor of Medicine, Public Health, and Psychology Director, Center for Obesity Research and Education Temple University

More information

When Diet and Exercise Aren t Enough: Pharmacologic Management of Obesity

When Diet and Exercise Aren t Enough: Pharmacologic Management of Obesity When Diet and Exercise Aren t Enough: Pharmacologic Management of Obesity Casey Bonaquist, DO Saturday, April 30 th, 2016 17 th Annual Primary Care & Cardiovascular Symposium Learning Objectives After

More information

Treating Lipids for Prevention of CAD in Women: Matching Therapy to Risk

Treating Lipids for Prevention of CAD in Women: Matching Therapy to Risk TREATING LIPIDS FOR PREVENTION OF CAD IN WOMEN: MATCHING THERAPY TO RISK Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery

More information

Overview. Stanley J. Rogers, MD, FACS Associate Clinical Professor of Surgery University of California San Francisco

Overview. Stanley J. Rogers, MD, FACS Associate Clinical Professor of Surgery University of California San Francisco GASTROINTESTINAL COMPLICATIONS AFTER BARIATRIC SURGERY Stanley J. Rogers, MD, FACS Associate Clinical Professor of Surgery University of California San Francisco UCSF DEPARTMENT OF SURGERY Original Article

More information

Associate. Professor of. Minimally. Invasive Surgery

Associate. Professor of. Minimally. Invasive Surgery Surgical Task Force Recommendations Ken Reed MD, FRSCS Committee Chair, and Staff Surgeon, Guelph General Hospital Clinical Associate Professor of Surgery, McMaster University Dennis Hong MD, MS.c, FRCSC,

More information

Management of Obesity. Objectives. Background Impact and scope of Obesity. Control of Energy Homeostasis Methods of treatment Medications.

Management of Obesity. Objectives. Background Impact and scope of Obesity. Control of Energy Homeostasis Methods of treatment Medications. Medical Management of Obesity Ben O Donnell, MD 1 Objectives Background Impact and scope of Obesity Control of Energy Homeostasis Methods of treatment Medications 2 O'Donnell 1 Impact of Obesity According

More information

Placebo-Controlled Statin Trials

Placebo-Controlled Statin Trials PREVENTION OF CHD WITH LIPID MANAGEMENT AND ASPIRIN: MATCHING TREATMENT TO RISK Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of

More information

Gastrointestinal Surgery for Severe Obesity 2.0 Contact Hours Presented by: CEU Professor

Gastrointestinal Surgery for Severe Obesity 2.0 Contact Hours Presented by: CEU Professor Gastrointestinal Surgery for Severe Obesity 2.0 Contact Hours Presented by: CEU Professor 7 www.ceuprofessoronline.com Copyright 8 2007 The Magellan Group, LLC All Rights Reserved. Reproduction and distribution

More information

Effective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D.

Effective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D. Effective Interventions in the Clinical Setting: Engaging and Empowering Patients Michael J. Bloch, M.D. Doina Kulick, M.D. UNIVERSITY OF NEVADA SCHOOL of MEDICINE Sept. 8, 2011 Reality check: What could

More information

Goals 1/9/2018. Obesity over the last decade Surgery has become a safer management strategy Surgical options for management

Goals 1/9/2018. Obesity over the last decade Surgery has become a safer management strategy Surgical options for management The Current State of Surgical Intervention in Management of Morbid Obesity Goals Obesity over the last decade Surgery has become a safer management strategy Surgical options for management 1 Goals Obesity

More information

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions April D. McNeill MD Candidate 2016, Southern Illinois University, School of Medicine GE-NMF Primary Care Leadership Program, July 2013

More information

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Disclosure No relevant

More information

Case 1. Relationship Between Fat Free Mass and 24-hour Energy Expenditure

Case 1. Relationship Between Fat Free Mass and 24-hour Energy Expenditure Difficult Cases of Obesity Management from Clinic Dan Bessesen, MD Professor of Medicine University of Colorado Chief of Endocrinology Denver Health Medical Center daniel.bessesen@ucdenver.edu Case 1 43

More information

Laparoscopic Adjustable Gastric Band The Safest, Effective Procedure for Treating Obesity and Obesity Related Disease

Laparoscopic Adjustable Gastric Band The Safest, Effective Procedure for Treating Obesity and Obesity Related Disease Laparoscopic Adjustable Gastric Band The Safest, Effective Procedure for Treating Obesity and Obesity Related Disease Erik Peltz, D.O. April 7 th, 2008 University of Colorado Health Science Center Department

More information

Session 6B Appropriate Treatment of Obesity Demonstrates Clinical & Economic Success

Session 6B Appropriate Treatment of Obesity Demonstrates Clinical & Economic Success Session 6B Appropriate Treatment of Obesity Demonstrates Clinical & Economic Success Part 2 John Dawson, FSA, MAAA Appropriate Treatment of Obesity Demonstrates Clinical & Economic Success SOA Asia-Pacific

More information